Primary |
Nuclear Magnetic Resonance Imaging |
46.0% |
Nuclear Magnetic Resonance Imaging Brain |
27.6% |
Angiogram |
4.8% |
Diagnostic Procedure |
4.5% |
Nuclear Magnetic Resonance Imaging Abdominal |
3.3% |
Drug Use For Unknown Indication |
1.6% |
Pain |
1.4% |
Back Pain |
1.3% |
Scan With Contrast |
1.3% |
Headache |
1.2% |
Convulsion |
1.1% |
Dizziness |
0.8% |
Peripheral Vascular Disorder |
0.8% |
Liver Scan |
0.7% |
Syncope |
0.7% |
Pain In Extremity |
0.6% |
Hiv Test Positive |
0.6% |
Hypertension |
0.6% |
Metastases To Central Nervous System |
0.6% |
Neoplasm |
0.6% |
|
Hypersensitivity |
22.7% |
Vomiting |
21.5% |
Urticaria |
11.0% |
Nausea |
8.8% |
Anaphylactoid Reaction |
6.9% |
Anaphylactic Reaction |
5.1% |
Nephrogenic Systemic Fibrosis |
3.1% |
Anaphylactic Shock |
2.9% |
Sneezing |
2.6% |
Cardiac Arrest |
2.1% |
Dyspnoea |
1.9% |
Loss Of Consciousness |
1.8% |
Throat Tightness |
1.8% |
Throat Irritation |
1.7% |
Pruritus |
1.4% |
Retching |
1.2% |
Erythema |
0.9% |
Renal Failure |
0.9% |
Renal Failure Acute |
0.8% |
Respiratory Arrest |
0.8% |
|
Secondary |
Nuclear Magnetic Resonance Imaging |
55.7% |
Angiogram |
13.6% |
Nuclear Magnetic Resonance Imaging Brain |
4.9% |
Drug Use For Unknown Indication |
4.5% |
Imaging Procedure |
4.5% |
Product Used For Unknown Indication |
3.7% |
Nuclear Magnetic Resonance Imaging Abdominal |
2.1% |
Venogram |
1.4% |
Diagnostic Procedure |
1.4% |
Fistulogram |
1.4% |
Pain |
1.4% |
Hypertension |
1.2% |
Anaemia |
0.7% |
Multiple Myeloma |
0.7% |
Arteriogram |
0.5% |
Headache |
0.5% |
Back Pain |
0.5% |
Scan |
0.4% |
Haemorrhage Intracranial |
0.4% |
Arteriogram Renal |
0.4% |
|
Pain |
21.7% |
Skin Tightness |
14.8% |
Nephrogenic Systemic Fibrosis |
12.9% |
Skin Fibrosis |
11.5% |
Scar |
10.0% |
Skin Induration |
5.1% |
Skin Hypertrophy |
2.7% |
Skin Ulcer |
2.4% |
Swelling |
2.2% |
Joint Range Of Motion Decreased |
1.9% |
Vomiting |
1.9% |
Anxiety |
1.6% |
Urticaria |
1.6% |
Anaphylactic Reaction |
1.5% |
Hypersensitivity |
1.4% |
Skin Lesion |
1.4% |
Oedema Peripheral |
1.4% |
Xerosis |
1.4% |
Skin Plaque |
1.3% |
Mobility Decreased |
1.2% |
|
Concomitant |
Drug Use For Unknown Indication |
25.4% |
Nuclear Magnetic Resonance Imaging |
23.8% |
Angiogram |
9.5% |
Imaging Procedure |
6.3% |
Liver Transplant |
6.3% |
Multiple Sclerosis |
6.3% |
Nuclear Magnetic Resonance Imaging Brain |
4.8% |
Acne |
3.2% |
Contraception |
3.2% |
Hypovitaminosis |
3.2% |
Colitis Ulcerative |
1.6% |
Computerised Tomogram |
1.6% |
Product Used For Unknown Indication |
1.6% |
Psoriatic Arthropathy |
1.6% |
Transient Ischaemic Attack |
1.6% |
|
Nephrogenic Systemic Fibrosis |
44.7% |
Nephrogenic Fibrosing Dermopathy |
7.9% |
Mental Status Changes |
5.3% |
Posterior Reversible Encephalopathy Syndrome |
5.3% |
Psychotic Disorder |
5.3% |
Skin Tightness |
5.3% |
Activities Of Daily Living Impaired |
2.6% |
Blood Glucose Increased |
2.6% |
Femoral Nerve Injury |
2.6% |
General Physical Health Deterioration |
2.6% |
Henoch-schonlein Purpura |
2.6% |
Muscular Weakness |
2.6% |
Pain |
2.6% |
Ph Urine Increased |
2.6% |
Somnolence |
2.6% |
Urticaria |
2.6% |
|